Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.
Legislative Progress
Introduced
February 25, 2026
Latest Action
February 25, 2026
Primary Sponsor
Josh GottheimerDemocratic(NJ)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 1,645 other HRES bills in the 119th — cohort avg 4d
This resolution recognizes that Charcot-Marie-Tooth (CMT) disease is significant and expresses the sense that CMT should receive robust funding for research. CMT disease is a neurological disorder that causes damage to the peripheral nerves.
Referred to the House Committee on Energy and Commerce.
Submitted in House
Congress.gov source codes: 1025, H11100
Bills with similar content found using semantic analysis.
Sources: Congress.gov